Experimental approaches to perceptual dysfunction in schizophrenia;Aproximaciones experimentales a la disfunción perceptual en la esquizofrenia

Revista de Neurologia

Volumn 37, Issue 6, 2003, Pages 545-551

  Gargiulo, Pascual Ángel ^a  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

Author keywords

Accumbens; Gestalt; Glutamate; NMDA; Perception; Schizophrenia

Indexed keywords

GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANXIETY; AVOIDANCE BEHAVIOR; BEHAVIORAL SCIENCE; BENDER TEST; ENVIRONMENTAL CHANGE; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PARAMETER; PERCEPTION DISORDER; PERCEPTIVE DISCRIMINATION; PERSEVERATION; PIGEON; REVIEW; ROTATION; SCHIZOPHRENIA; TASK PERFORMANCE;

EID: 0242569646     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3706.2003351     Document Type: Review

References (80)

1. Kraépelin E. Psychiatrie. 5. Leipzig: Ausg. Barth.; 1896.
2. Bleuler E. Dementia praecox oder die Gruppe der Schizophrenien, in Aschaffenburg, Handbuch der Psychiatrie. Leipzig: Deuticke; 1911.
3. Cutting J, Dunne F. The nature of the abnormal perceptual experiences at the onset of schizophrenia. Psychpathology 1986; 19: 347-52.
4. Jaspers K. Allgemeine Psychopathologie. Berlin: Springer; 1913.
5. Schmidt G. Der Wahn im deutschsprachigen Schrifttum der letzten 25 Jahre. Zentbl Ges Neurol Psychiat 1940; 97: 113-43.
6. Conrad K. Die Beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns. Stuttgart: Thieme; 1966.
7. Weckowicz TE. Size constancy in schizophrenic patients. J Ment Sci 1957; 103: 475-86.
8. Mc Ghie A, Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol 1961; 34: 103-15.
9. Freedman BJ. The subjective experience of perceptual and cognitive disturbances in schizophrenia. Arch. Gen Psychiat 1974; 30: 333-40.
10. Gross G, Huber G. Sensorische Störungen bei Schizophrenien. Arch Psychiat NervKrankh 1972; 216: 119-30.
11. Phillipson OT, Harris JP. Perceptual changes in schizophrenia: a questionnaire survey. Psychol Med 1985; 15: 859-66.
12. Matussek P. Untersuchungen über die Wahnwahrnehmungen. Arch Psychiat NervKrankh 1952; 189: 279-318.
13. Del Vecchio S, Gargiulo PA. Visual and motor function in schizophrenic patients. Acta Psiquiat Psicol Am Lat 1992; 38: 317-22.
14. Gargiulo PA, Del Vecchio S. Gestaltic visual motor function in schizophrenic patients. In Elsner N, Wässle H. Göttingen Neurobiology Report 1997. Proceedings of the 25th Göttingen Neurobiology Conference 1997. Vol. II. Stuttgart: Thieme; 1997. Communication 1005.
15. Kleinman JE, Gillin JC, Wyatt RJ. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Schizophr Bull 1977; 3: 560-86.
16. Place EJS, Gilmore GC. Perceptual organization in schizophrenia. J Abn Psychol 1980; 89: 409-18.
17. Wells DS, Leventhal DB. Perceptual grouping in schizophrenia: a replication of Place and Gilmore. J Abn Psychol 1984; 93: 231-4.
18. Rief W. Visual perceptual organization in schizophrenic patients. Br J Clin Psychol 1991; 30: 359-66.
19. Chey J, Holzman PS. Perceptual organization in schizophrenia: utilization of the Gestalt principles. J Abn Psychol 1997; 106: 530-8.
20. John, CH, Hemsley DR. Gestalt perception in schizophrenia. Eur Arch Psychiatry Clin Neurosci 1992; 241: 215-21.
21. Arieti S. The psychotherapeutic approach to schizophrenia. In Kemuli D, Bartholoni G, Richter D, eds. Schizophrenia Today. Oxford: Pergamon; 1976.
22. Koppitz EM. El test gestáltico visomotor para niños. Buenos Aires: Guadalupe; 1980.
23. Robbins TW. Cognitive deficits in schizophrenia and Parkinson's disease: neural basis and the role of dopamine. In Willner P, Scheel-Kruger J, eds. The mesolimbic dopamine system: from motivation to action. New York: Wiley; 1991.
24. Parnas J, Vianin P, Saebye D, Jansson L, Volmer-Larsen A, Bovet P. Visual binding abilities in the initial and advanced stages of schizophrenia. Acta Psychiatr Scand 2001; 103: 171-80.
25. Fleminger S. Seeing is believing: the role of 'preconscious' perceptual processing in delusional misidentification. Br J Psychiatry 1992; 160: 293-1303.
26. Mintz S, Albert M. Imagery vividness, reality-testing and schizophrenic hallucinations. J Abn Psychol 1972; 79: 310-6.
27. Slade PD, Bentall RP. Sensory deception: a scientific analysis of hallucinations. London: Croom Helm; 1988.
28. Cutting J, Murphy D. Schizophrenic thought disorder. A psychological and organic perspective. Br J Psychiatry 1988; 152: 310-9.
29. Frith CD. The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med 1987; 17: 631-48.
30. Morrison RL, Bellack AS, Mueser KT. Deficits in facial-affect recognition and schizophrenia. Schizophr Bull 1988; 14: 67-83.
31. Schwartz BL, Rosse RB, Johri S, Deutsch SI. Visual scanning of facial expressions in schizophrenia. J Neuropsychiatry Clin Neurosci 1999; 11: 103-106.
32. Gargiulo PA, Martinez G, Ropero C, Funes A. Landa AI. NMDA glutamatergic blockade of nucleus accumbens disrupts acquisition but not consolidation in a passive avoidance task. Ann N Y Acad Sci 1999; 877: 717-22.
33. Mogenson GJ, Jones DL, Yim CY. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980; 14: 69-97.
34. Koob GF. Neural mechanisms of drug reinforcement. In Kalivas PW, Samson HH. The neurobiology of drug and alcohol addiction. Ann N Y Acad Sci 1992; 654: 171-91.
35. Carlsson M, Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull 1990; 16: 425-32.
36. Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS IV, Penney JB, Young AB. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative auto radiographic study. Neurosci 1991; 46: 35-48.
37. Karten HJ, Hodos WA. Stereotaxic atlas of the brain of the pigeon. Baltimore: Johns Hopkins Press; 1967.
38. Veenman CL, Wild JM, Reiner A. Organization of the avian 'corticostriatal' projection system, a retrograde and anterograde pathway tracing study in pigeons. J Comp Neurol 1995; 354: 87-126.
39. Gargiulo PA, Siemann M, Delius JD. Visual discrimination in pigeons impaired by glutamatergic blockade of nucleus accumbens. Physiol Behav 1998; 63: 705-9.
40. Groenewegen HJ, Vermeulen-van der See E, Te Kortschot A, Witter MP. Organization of the projections from the subiculum to the ventral striatum in the rat: a study using anterograde transport of Phasealus vulgaris leucoagglutinin. Neurosci 1987; 23: 103-20.
41. Pennartz CMA, Groenewegen HJ, Lopes da Silva F. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 1994; 42: 719-61.
42. Gargiulo PA. Thyrotropin releasing hormone injected into the nucleus accumbens septi selectively increases face grooming in rats. Braz J Med Biol Res 1996; 29: 805-10.
43. Salamone JD. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res 1994; 61: 117-33.
44. Scheel-Kruger J, Willner P. The mesolimbic system: principles of operation. In Willner P, Scheel-Kruger J, eds. The mesolimbic dopamine system: from motivation to action. New York: Wiley; 1991. p. 559-97.
45. Seamans JK, Phillips AG. Selective memory impairments produced by transient lidocaine-induced lesions of the nucleus accumbens in rats. Behav Neurosci 1994; 108: 456-68.
46. Setlow B. The nucleus accumbens and learning and memory. J Neurosci Res 1997; 49: 515-21.
47. Setlow B, McGaugh JL. Sulpiride infused into the nucleus accumbens posttraining impairs memory of spatial water maze training. Behav Neurosci 1998; 112: 603-10.
48. Ammasari-Teule M, Fagioli S, Rossi-Arnaud C. Genotype-dependent involvement of limbic areas in spatial learning and postlesion recovery. Physiol Behav 1992; 52: 505-10.
49. Annett LM, Mc Gregor A, Robbins TW. The effects of ibotenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat. Behav Brain Res 1989; 31: 231-42.
50. Roullet P, Mele A, Ammasari-Teule M. Ibotenic lesions of the nucleus accumbens promote reactivity to spatial novelty in nonreactive DBA mice: implications for neural mechanisms subserving spatial information encoding. Behav Neurosci 1997; 111: 976-84.
51. Usiello A, Sargolini F, Roullet P, Amassari-Teule M, Passino E, Oliverio A, et al. N-methyl-D-aspartate receptors in the nucleus accumbens are involved in detection of spatial novelty in mice. Psychopharmacol 1998; 137: 175-83.
52. Kiyatkin E. Functional significance of mesolimbic dopamine. Neurosci Biobehav Rev 1995; 19: 573-98.
53. Kim JS, Levin ED. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. Brain Res 1996; 725: 231-40.
54. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999; 3: 11-21.
55. Matthysse S. Nucleus accumbens septi and schizophrenia. In Chronister RB, De France JF, eds. The neurobiology of the nucleus accumbens. Proceedings of the Symposium: Nucleus Accumbens. Sebasco Estates, Maine: Haer Institute for Electrophysiological Research; 1980. p. 351-9.
56. Jain AK, Kelwala S, Gershon S. Antipsychotic drugs in schizophrenia: current issues. Internat Clin Psychopharmacol 1988; 3: 1-30.
57. Crow TJ, Deakin JFW, Longden A. Do antipsychotic drugs act by dopamine receptor blockade in the nucleus accumbens? Br J Pharmacol 1975; 55: 295.
58. McKinney WT, Bunney WE. Animal models of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 1969; 21: 240-8.
59. Mc Kinney W, Moran EC. Animal models of schizophrenia. Am J Psychiatry 1981; 138: 478-83.
60. Geyer MA, Markou A. Animal models of psychiatric disorders. In Bloom FE, Kupfer DJ, eds. Psychopharmacology. The fourth generation of progress. New York: Raven Press; 1995. p. 787-98.
61. Brandeis R, Brandys Y, Yehuda S. The use of the Morris water maze in the study of memory and learning. Internat J Neurosci 1989; 48: 29-69.
62. Gal G, Joel D, Gusak O, Feldon, J, Weiner I. The effects of electrolytic lesion to the shell subterritory of the nucleus accumbens on delayed non-matching-to-sample and four-arm baited eight-arm radial-maze tasks. Behav Neurosci 1997; 111: 92-103.
63. Gray JA, McNaughton N. Comparison between the behavioral effects of septal and hippocampal lesions: a review. Neurosci Biobehav Rev 1983; 7: 119-88.
64. Jarrard LE. Selective hippocampal lesions and behavior: implications for current research and theorizing. In Isaacson RL, Pribram KH, eds. The hippocampus. Vol. 4. New York: Plenum Press; 1986. p. 93-122.
65. Reading PJ, Dunnett SB. The effects of excitotoxic lesions of the nucleus accumbens on a matching to position task. Behav Brain Res 1991; 46: 17-29.
66. Sutherland RJ, Rodriguez AJ. The role of the fimbria/fornix and some related subcortical structures in place memory and learning. Behav Brain Res 1989; 32: 265-77.
67. Taghzouti K, Louilot A, Herman GP, Le Moal M, Simon H. Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat. Behav Neural Biol 1985; 44: 354-63.
68. Taghzouti K, Simon H, Louilot A, Herman GP, Le Moal, M. Behavioral study after local injection of 6-hydroxydopamine into the nucleus accumbens in the rat. Brain Res 1985; 344: 9-20.
69. Acerbo MJ, Gargiulo PA, Krug I, Delius JD. Behavioural consequences of nucleus accumbens dopaminergic stimulation and glutamatergic blocking in pigeons. Behav Brain Res 2002; 136: 171-7.
70. Deutsch SI, Mastropaolo J, Schwartz WL, Rosse RB, Morihisa JM. A glutamatergic hypothesis of schizophrenia. Clin Neuropharm 1989; 12: 1-13.
71. Martinez G, Ropero C, Funes A, Tirapu V, Flores E, Landa AI, et al. AP-7 into the nucleus accumbens septi disrupts acquisition but not consolidation in a passive avoidance task. In Elsner N, Eysel U, eds. Göttingen Neurobiology Report 1999. Proceedings of the First Göttingen Conference of the German Neuroscience Society 1999. Vol. II. 27th Göttingen Neurobiology Conference. Sttutgart: Thieme; 1999. p. 760.
72. Martinez G, Ropero C, Funes A, Flores E, Landa AI, Gargiulo PA. AP-7 into the nucleus accumbens disrupts acquisition but does not affect consolidation in a passive avoidance task. Physiol Behav 2002; 76: 205-12.
73. Jessa M, Nazar M, Plaznik A. Effects of intra-accumbens blockade of NMDA receptors in two models of anxiety, in rats. Neurosci Res Comm 1996; 19: 19-25.
74. Blotta C, Maravilla G, Martinez G, Ropero C, Funes A, Flores E, et al. Dizocilpine (MK-801) and cycloleucine into the nucleus accumbens septi induce an anxiolitic-like effect in rats in the plus maze test. In Elsner N, Eysel U, eds. Göttingen Neurobiology Report 1999. Proceedings of the First Göttingen Conference of the German Neuroscience Society 1999. Vol. II. 27th Göttingen Neurobiology Conference. Strutgart: Thieme; 1999. p. 757.
75. Maravilla G, Blotta C, Ropero C, Funes A, Flores E, Martinez G, et al. AP-7 and NBQX into the nucleus accumbens septi induce an anxiolitic-like effect in rats in the plus maze test. In Elsner N, Eysel U, eds. Göttingen Neurobiology Report 1999. Proceedings of the First Göttingen Conference of the German Neuroscience Society 1999. Vol. II. 27th Göttingen Neurobiology Conference. Sttutgart: Thieme; 1999. p. 758.
76. Martinez G, Ropero C, Funes A, Flores E, Blotta C, Landa AI, et al. Effects of NMDA and non-NMDA blockade in the nucleus accumbens on the plus maze test. Physiol Behav 2002; 76: 219-24.
77. Garland-Bunney B, Bunney WE, Carlsson A. Schizophrenia and glutamate. In Bloom FE, Kupfer DJ, eds. Psychopharmacology. The fourth generation of progress. New York: Raven Press; 1995. p. 1205-14.
78. Luby ED, Cohen BD, Rosenbaum F, Gottlieb J, Kelley R. Study of a new schizophrenomimetic drug, Sernyl. Arch Neurol Psychiatry 1959; 8: 363-9.
79. Heresco-Levy U, Javitt DC, Zukin SR. The phencyclidine/N-methyl-D-aspartate (PCP/NMDA) model of schizophrenia: theoretical and clinical implications. Psychiatry Ann 1993; 23: 135-43.
80. Robbins TW. The case for frontostriatal dysfunction in schizophrenia. Schizophr Bull 1990; 16: 391-402.